FDA Inspection 1221082 — South Texas Blood and Tissue Center

South Texas Blood and Tissue Center — FEI 3007003817

The FDA completed an inspection of South Texas Blood and Tissue Center on October 18, 2023 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 18, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Antonio, TX (United States)